Phase I dose escalation clinical trial of phenylbutyrate sodium administered twice daily to patients with advanced solid tumors

By Camacho Luis   Olson Jon   Tong William   Young Charles   Spriggs David   Malkin Mark  

Investigational New Drugs, Vol. 25, Iss. 2, 2007-04 ,pp. : 131-138

Springer Publishing Company

Access to resources Recommend Favorite

A Bayesian Approach for Dose-Escalation in a Phase I Clinical Trial Incorporating Pharmacodynamic Endpoints

By Whitehead John  

Journal of Biopharmaceutical Statistics, Vol. 17, Iss. 6, 2007-11 ,pp. : 1117-1129

Taylor & Francis Ltd

Access to resources Recommend Favorite

A phase I safety and dose escalation trial of docetaxel combined with GEM®231, a second generation antisense oligonucleotide targeting protein kinase A R1α in patients with advanced solid cancers

By Goel Sanjay   Desai Kavita   Macapinlac Manuel   Wadler Scott   Goldberg Gary   Fields Abbie   Einstein Mark   Volterra Fabio   Wong Benny   Martin Russell   Mani Sridhar  

Investigational New Drugs, Vol. 24, Iss. 2, 2006-03 ,pp. : 125-134

Springer Publishing Company

Access to resources Recommend Favorite

Phase I Trial of Dose-Dense Docetaxel and Doxorubicin with or without Sargramostim in Patients with Metastatic Breast Cancer

By Montero Alberto   Booser Daniel   Esparza-Guerra Laura   Murray James   Rosales Marguerite   Hortobagyi Gabriel   Valero Vicente  

Drugs in R&D, Vol. 6, Iss. 5, 2005-01 ,pp. : 299-305

Adis International

Access to resources Recommend Favorite

A phase I dose escalation study of Nimotuzumab in combination with concurrent chemoradiation for patients with locally advanced squamous cell carcinoma of esophagus

By Zhao Kuai-le  

Investigational New Drugs, Vol. 30, Iss. 4, 2012-08 ,pp. : 1585-1590

Springer Publishing Company

Access to resources Recommend Favorite